The Lever - The Next Abortion Battle

Older messages

LEVER WEEKLY: The Long Reach Of A Secretive Megadonor

Sunday, September 11, 2022

This week, The Lever pulled back the curtain on billionaire dark money donor Barre Seid. LEVER WEEKLY: The Long Reach Of A Secretive Megadonor By Ricardo Gomez – 11 Sep 2022 – View online → (Credit:

YOU LOVE TO SEE IT: Trump Era Fossil Fuel Leases Are A No-Go

Saturday, September 10, 2022

Also, Vancouver aims to sue Big Oil, a district court affirmed Biden's pause on fossil fuel leasing, the Federal Reserve will start acting on climate change, and Hawaii closes its last coal plant.

Will Anyone Stop Manchin’s Climate Bomb?

Friday, September 9, 2022

Many lawmakers are criticizing the Schumer-Manchin climate bomb — but only a few have pledged to do what may be necessary to stop it. Will Anyone Stop Manchin's Climate Bomb? By The Lever – 09 Sep

Amazon And Starbucks Finally Feel The Heat

Thursday, September 8, 2022

On this week's Lever Time: David examines Joe Biden's recent rhetoric concerning democracy, exposes the dark side of Biden's student debt policy, and dives into Amazon and Starbucks workers

The Billionaire Behind The Curtain

Wednesday, September 7, 2022

Leonard Leo's benefactor has also been quietly financing climate denial and the right's judicial pipeline. The Billionaire Behind The Curtain By The Lever – 07 Sep 2022 – View online → After

You Might Also Like

Full-crime job

Friday, April 26, 2024

Lawyers for Trump argued before SCOTUS that the president has "total immunity" ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

All of My Friends Have These Sweatpant Jeans

Friday, April 26, 2024

Here's What You Missed on the Strategist The Strategist Every product is independently selected by editors. If you buy something through our links, New York may earn an affiliate commission. All of

🌈 Live a bold & bright life

Friday, April 26, 2024

Introducing our theme for May plus fun stuff to read, watch, and click on curated by CreativeMornings HQ. April 25, 2024 Open in new tab Did a friend forward this? Subscribe today! Speech bubble logo

🕐 Time Is Running Out: Your $99 Offer Expires In 48 Hours

Thursday, April 25, 2024

This advisory has returned a massive 838% since inception compared to the 273% return from the S&P 500 Final 48 Hours Fellow Investor, We recently sent you an exclusive offer to try our flagship

The Professor Protesting Columbia’s Own Students

Thursday, April 25, 2024

Columns and commentary on news, politics, business, and technology from the Intelligencer team. Intelligencer THURSDAY, APRIL 25 The Professor Protesting Columbia's Own Students Shai Davidai, a

Before you lose your phone ...

Thursday, April 25, 2024

Do these things now ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

Friday Briefing: Supreme Court hears Trump immunity case

Thursday, April 25, 2024

Also, more bodies found in a Gazan mass grave. View in browser|nytimes.com Continue reading the main story Ad Morning Briefing: Asia Pacific Edition April 26, 2024 Author Headshot By Amelia Nierenberg

Microsoft results beat quarterly expectations as profits rise 20% to nearly $22B

Thursday, April 25, 2024

Breaking News from GeekWire GeekWire.com | View in browser BREAKING NEWS Microsoft posted a 17% increase in revenue, to $61.9 billion, with $21.9 billion in profits, up 20%, and earnings of $2.94 per

The Dark Side of Immune

Thursday, April 25, 2024

SCOTUS and Why It's Good to be the King ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

Techie-turned-lawmaker uses Microsoft chops as state senator | ‘Acquired’ podcast hosts raising fund

Thursday, April 25, 2024

Amazon to stream Seattle Kraken games | Impinj stock soars | 'Good to Go!' scam warning ADVERTISEMENT GeekWire SPONSOR MESSAGE: Science Firsthand: Learn how Bristol Myers Squibb unlocked the